GALD Stock Price, Chart, Stats & News
Galderma Group AG (GALD) is a dividend-paying stock with a current dividend yield of 0.20% as of Aug 21, 2026. It pays 0.3500 CHF per share over the trailing twelve months and distributes annually.
Dividend safety
Dividend coverage looks healthy — GALD pays out about 12% of earnings.
GALD chart
About
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology.
Related lists
Similar securities
Based on sector and market capitalization
